Global, regional, and national burden of chronic kidney disease, 1990–2021: Results from the global burden of disease study 2021

Diabetes Res Clin PractPublished Secondary analysis of the Global Burden of Disease 2021 study

Authors' conclusion

The global CKD burden continues to rise, with substantial disparities across regions, ages, genders, and socioeconomic levels.

Study context

Population
Global, regional and national CKD burden, 1990–2021, Global Burden of Disease (GBD) 2021 database
Methodological detailsEstimated annual percentage change (EAPC) and Joinpoint regression, decomposition analysis
  • EAPC and Joinpoint regression
  • Decomposition analysis

Primary result

As reported in the abstract

Global CKD burden · 2021

People affected by CKD globally

674 million

New cases

19.93 million

Deaths

1.528 million

Disability-adjusted life years (DALYs)

44.45 million

Further findings

Annual increase in global ASR, 1990–2021

Incidence ASR annual increase (p < 0.05)
0.64
Mortality ASR annual increase (p < 0.05)
0.82
DALY ASR annual increase (p < 0.05)
0.37
  • All p < 0.05

Burden by Socio-Demographic Index (SDI)

Correlation of incidence EAPC with SDI (p = 0.012)
R = −0.135
High-SDI regions showed the fastest growth in mortality and DALY burden; low-SDI regions, despite higher overall burden, showed declines in some indicators
CKD burden showed a nonlinear association with SDI

Decomposition of rising CKD burden

Population growth contribution
54.75%
Aging contribution
26.71%

Original publication

Global, regional, and national burden of chronic kidney disease, 1990–2021: Results from the global burden of disease study 2021. Diabetes Res Clin Pract. Published 15 July 2026. doi:10.1016/j.diabres.2026.113381

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.